Amy Belt Raimundo is the Chief Business Officer for Evidation Health where she leads all commercial and business development activities. Previously, Amy focused on venture investing is the medical device sector as a Vice President at both Covidien Ventures and Advanced Technology Ventures (ATV). Before joining ATV, Amy was at Guidant Corporation (later Abbott Vascular) where she led the international launch of the Xience drug eluting stent and managed product lines in the US, Europe and Asia. She began her career as a Management Consultant for APM/CSC Healthcare, optimizing clinical guidelines and operations for major hospital systems. Amy is a Kauffman Venture Fellow and holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.
Amy Belt Raimundo
Deborah Kilpatrick, PhD
Deb Kilpatrick is the CEO of Evidation Health, a digital health company backed by B Capital, GE Ventures, Asset Management Ventures, and Rock Health. Evidation quantifies outcomes in the digital era of medicine through machine learning and analytics of medical and behavior data in connected populations. Previously, Deb was Chief Commercial Officer of genomic diagnostics company CardioDx, a past winner in the Wall Street Journal Technology Innovation Awards and the Edison Awards. She formerly held multiple roles at Guidant Corporation, including Research Fellow, Director of R&D and Director of New Ventures. She chairs the Georgia Tech College of Engineering Advisory Board and is a Fellow of the American Institute of Medical and Biological Engineering. Deb has been named to FierceBiotech’s Top Women in Biotech, FierceMedicalDevice’s Top Women in Medtech, and Silicon Valley Business Journal’s 100 Women of Influence. She holds BS, MS and PhD degrees in engineering from Georgia Tech.
Jacqué Ashby is an Executive Assistant & Office Manager, Volunteer Event Manager and a Certified Sommelier. Prior to Credence, she spent three and a half years at Aptus Endosystems, four years at FlowCardia/BPV, five years at Kyphon, and two years at Arthrocare, where her various roles included Executive Assistant, Physician Training Coordinator, Sales Support Supervisor, and CSR. Through these various roles, a passion developed for Event Planning and Management of all meeting types, domestically and internationally: industry tradeshows, board meetings, sales meetings, incentive trips, physician advisory board, etc. Jacqué is multi-lingual, holds a BA in French with a German minor from SJSU, a Culinary Arts Diploma from PCI (now ICC California), an Intensive Sommelier Program Diploma from ICC California, a Court of Master Sommelier’s Certified Sommelier Certification, and is the recipient of the Bert Cutino Award for Culinary Excellence.
Jennifer T. Beedon
Jennifer Beedon is a healthcare executive and creative thinker who brings 20 years of operational, consulting and general management experience to her clients. She partners with early stage CEOs and entrepreneurs to develop business plans to attract investment and build market entry strategies. Fortune 500 companies seek Jennifer’s expertise to evaluate compelling business opportunities, providing the foundation for strategic investment. Prior to founding her own firm, Jennifer held international and domestic leadership roles in business development, marketing and manufacturing operations at Guidant Corporation (now Abbott Vascular) and 3M. Jennifer is a co-founder of MedtechWomen. She holds an MBA from Harvard Business School and a BS in chemical engineering from the University of Michigan.
Amanda DePalma is the Vice President of Global Marketing at Endologix. Her responsibilities include global marketing, strategic planning, new product development, and brand management. Ms. DePalma has more than 19 years of medical device marketing and sales experience. Prior to joining us, Ms. DePalma held the position of Senior Director, Global Strategic Marketing at Edwards Lifesciences where she led the global strategy, business development and branding efforts for the Critical Care business unit. From 2005 to 2011 Ms. DePalma had positions of increasing responsibility at Kimberly-Clark Healthcare (now Halyard Health) including General Manager and Director of Global Strategic Marketing. Prior to that, Ms. DePalma held marketing positions at Guidant Corporation and Abbott Vascular. Ms. DePalma holds a B.S. in Marketing and an M.B.A. from the University of Florida Warrington College of Business.
Virginia L. Giddings
Virginia Giddings heads Advanced Technology & Innovation at Stryker Neurovascular, leading technology strategy and innovation to treat stroke. Previously at Abbott, she led Strategic R&D for the Nutrition division, with global responsibility for early-stage research and science partnerships. Also at Abbott, she played a key role in US approval of XIENCE V drug eluting stent and led the technical strategy for ABSORB, a novel bioabsorbable stent, resulting in first of kind CE Mark approval and EU launch. A patent agent, she had IP strategy roles with J&J and Advanced Stent Technologies. She serves on the Cornell Engineering Council, President’s Council of Cornell Women, Georgia Tech-Emory Bioengineering Board and is a Fellow of the American Institute of Medical and Biological Engineering. She is a co-founder of MedtechWomen. She received Bachelor’s and Master’s in Mechanical Engineering from Cornell University and a Ph.D. in Biomechanical Engineering from Stanford.
Bridget has over 16 years of US and International experience in product development and clinical trial management. She currently heads up Clinical and Regulatory for Element Science, a medical device company focused on developing a wearable therapeutic device for treatment of sudden cardiac death. Prior to this role, Bridget was the VP of Clin/Reg for Pulmonx and has held several management roles in R&D and Clinical at Abbott Vascular and Guidant. On the R&D side, Bridget played an integral role in the design and development of the XIENCE V drug-eluting stent program and the MitraClip percutaneous mitral valve repair system. On the clinical side, Bridget was based in Brussels as the Director for the EMEA Clinical and oversaw the international clinical operations for coronary and endovascular applications. Bridget holds a BS in Mechanical Engineering from The University of Texas at Austin, and an MS in Mechanical Engineering from Georgia Institute of Technology.
Azadeh Nasibi is a Director of Business Development & Strategy at Medtronic’s Brain business unit, covering Neurovascular and Brain Modulation. Her responsibilities include market opportunity analysis, target landscaping, and deal execution across the continuum of care of Brain diseases. Prior to joining Medtronic, Azadeh was a Manager in Deloitte Consulting’s Life Sciences practice, specializing in Strategy and Operations, consulting for biotech and medtech clients ranging from start-ups to Fortune 500 corporations. She holds an MBA from the Anderson School of Management at the University of California at Los Angeles. Prior to her MBA, Azadeh worked in the high- tech industry as an IT consultant and software engineer. She received her BS in Information and Computer Science from the University of California at Irvine.
Leslie Oley is the Head of Growth Product at Evidation Health, where she is responsible for product vision and user growth. Evidation quantifies outcomes in the digital era of medicine by applying data analytics to medical and behavior data in connected populations – and she’s excited about the significant opportunities at the intersection of technology, outcomes-based medicine, and consumer design. Previously, Leslie was the Director of Marketing at ApniCure, where she led product strategy and marketing for a consumer sleep apnea therapy, which has been awarded IDEA and Wall Street Journal Technology Innovation Awards. She formerly held multiple roles working on the development and commercialization of new medical therapies at Boston Scientific, Voyage Medical, and as an independent consultant. Leslie earned a BS in Mechanical Engineering from Penn State, and a master’s degree in M.E. (Biomechanics) from Stanford, where she conducted NSF-funded research in cardiovascular mechanics.
As founder of her own firm, Nicole works closely with companies and physicians to highlight innovation and leadership in the field of health care. Her targeted public relations and social media programs have brought life-transforming medical technologies to the forefront for millions of Americans. Based in Menlo Park, Calif., Nicole’s clients include Abbott, CardioKinetix, Ceterix Orthopaedics, Intersect ENT, NeoTract, Outset Medical, Pelvalon, Shockwave Medical. She was named a 2015 PR Executive of the Year by Business Intelligence Group.
Laura is a seasoned commercial leader with experience in diagnostics, digital health, pharma, and medical devices. At Ruckus Partners, she provides on-demand commercial leadership to help start-up to Fortune 500 companies develop marketing and pricing strategies. Prior to establishing Ruckus Partners with, Marijka Annis, she led marketing for several health care companies including Diadexus, Sequenta, Genoptix (Novartis), and was a brand director at Amylin Pharmaceuticals. Her efforts resulted in increased annual sales growth, development of KOL relationships and collaborations and the launch of nearly two dozen products.
Laura serves as an advisor to LaunchPad Digital Health, CLSA FAST Program and is on the core team of MedtechWomen. She holds a BA from UCSC and and MBA from UC Berkeley, Haas School of Business.
Natalie Shlafman advises medical technology companies on product strategy, commercialization and marketing. Natalie was Vice President of Marketing until 2015 at CardioDx, a cardiovascular genomic diagnostics company in Redwood City, CA. She joined the company in 2006 with responsibility to build out the company’s marketing capabilities. She led product marketing, strategic and managed care marketing, communications, and market research. Prior to joining CardioDx, Natalie was in the Vascular Intervention Division of Guidant Corporation, where she worked in market development within the New Ventures unit and in product marketing within the Angioplasty Systems group. Natalie received her MBA from the Kellogg School of Management at Northwestern University. Prior to her MBA, Natalie worked in the high-tech industry and held product marketing roles at LogicTier and at SGI. Natalie received her BA in psychology with a business specialization from UCLA.
With 20 years of experience in the healthcare arena, Susan is recognized as a respected leader and expert in commercialization of new medical technologies. Joining Intersect ENT as the 10th employee in 2007, Susan has played an instrumental role in building the company from R&D stage to a high growth commercial business leading the areas of Marketing, Customer Service and International Expansion. Susan has impacted top priority products from the aspects of marketing, sales, R&D, clinical research, and manufacturing at both start-up and large companies including many years at Guidant. Ms. Stimson holds a B.S. in Biomedical Engineering from Marquette University.